Initial Testing (Stage 1) the Pediatric Preclinical Testing Program of RO4929097, a γ-Secretase Inhibitor Targeting Notch Signaling

RO4929097 is a potent and selective inhibitor of γ-secretase and as a result is able to inhibit Notch pathway signaling. The activity of RO4929097 was evaluated against the in vivo panels of the Pediatric Preclinical Testing Program (PPTP). RO4929097 induced significant differences in event-free sur...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kolb, E. Anders, Gorlick, Richard, Keir, Stephen T., Maris, John M., Lock, Richard, Carol, Hernan, Kurmasheva, Raushan T., Reynolds, C. Patrick, Kang, Min H., Wu, Jianrong, Houghton, Peter J., Smith, Malcolm A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276746/
https://ncbi.nlm.nih.gov/pubmed/22052798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23290
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg